Federal award (DELIVERY ORDER, fiscal year 2021)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2021-12-27 to 2022-01-19
Current total value of award: $2272.4
Description: 4555803196!OMIDRIA 1-0.3% VIAL 4ML